• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Long-term users of e-cigarettes have decreased carcinogen and toxin levels compared to users of combustible cigarettes

byEvelyn NguyenandDeepti Shroff Karhade
February 7, 2017
in Chronic Disease, Oncology, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Former smokers who used only e-cigarettes or only nicotine replacement therapy (NRT) for ≥6 months (long-term) were found to have generally similar levels of nicotine but considerably reduced levels of measured carcinogens and toxins compared to users of combustible cigarettes (either solely or along with e-cigarettes or NRT).

2. The data suggests that although e-cigarettes may be useful as an aid for smokers who have struggled to quit by other means, health benefits are not obtained unless smoking of combustible cigarettes is ceased completely.

Evidence Rating Level: 4 (Below Average)

Study Rundown: E-cigarettes have quickly gained popularity, but there are concerns about the possible negative health effects of e-cigarettes. This cross-sectional study compared participant data from 5 groups: users of only combustible cigarettes, former smokers with long-term use of only e-cigarettes or only NRT, and long-term users of both combustible cigarettes and e-cigarettes or both combustible cigarettes and NRT. Former smokers with long-term use of only e-cigarettes or only NRT were found to have generally similar levels of nicotine compared to users of combustible cigarettes. Considerable reduction in levels of measured carcinogens and toxins were found in long-term users of only e-cigarettes or only NRT compared to those who used combustible cigarettes (either solely or along with e-cigarettes or NRT). The data suggests that although e-cigarettes may be useful as an aid for smokers who have struggled to quit by other means, health benefits are not obtained unless smoking of combustible cigarettes is ceased completely.

A strength of this study is that it is the first study to directly compare nicotine, carcinogen, and toxin metabolite levels in long-term users of e-cigarettes or NRT. Limitations of the study include a self-selected sample, a sample size that may not be large enough to capture any important small differences in levels of exposure, lack of indirect exposure assessment, and analysis limitations caused by spot sampling and the number of available biomarkers.

Click to read the study, published today in Annals of Internal Medicine

Relevant Reading: Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review

RELATED REPORTS

Combination treatment with varenicline and nicotine patch improves smoking cessation outcomes for concurrent alcohol users

Nicotine e-cigarettes may help young adults stop smoking

Wellness Check: Addictions

In-Depth [cross-sectional study]: In London from January 2014 to June 2014, researchers collected data from 181 participants divided into the following 5 groups (n = 36 to 37 per group): users of only combustible cigarettes, former smokers with ≥6 months use of only e-cigarettes or only nicotine replacement therapy (NRT), and users of both combustible cigarettes and e-cigarettes or both combustible cigarettes and NRT for ≥6 months. Data included questionnaires completed by the participants and laboratory analysis of breath, saliva, and urine samples. In general, participants were mainly male, white, and young with at least a high school education. There were no distinct differences between groups in nicotine intake biomarkers in saliva or urine. Metabolite levels for tobacco-specific N-nitrosamines (TSNAs), including 4-(methylnitrosamino)-1-(3pyridyl)-1-butanol (NNAL), a carcinogenic metabolite, were significantly lower in e-cigarette only or NRT only users compared to the three other groups (p < 0.001). NNAL levels were lowest in users of only e-cigarettes, with a 97% reduction compared to users of only combustible cigarettes. Levels of volatile organic compounds (VOCs) were also significantly lower in users of only e-cigarettes or only NRT compared to the three other groups (p < 0.001).

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: nicotinesmoking cessation
Previous Post

Recommendations for Childhood and Adolescent Immunizations

Next Post

Obesity leaves patients vulnerable to suboptimal end-of-life care

RelatedReports

Secondhand smoke exposure counseling may be insufficient amongst cardiology inpatients
Chronic Disease

Combination treatment with varenicline and nicotine patch improves smoking cessation outcomes for concurrent alcohol users

April 7, 2022
Smokeless tobacco use in children has not changed
Wellness

Nicotine e-cigarettes may help young adults stop smoking

October 25, 2021
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Wellness

Wellness Check: Addictions

October 21, 2021
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Standard cytisine treatment for smoking cessation does not demonstrate noninferiority compared to standard varenicline treatment

July 7, 2021
Next Post
Increased risk of stillbirth recurrence after a previous stillbirth

Obesity leaves patients vulnerable to suboptimal end-of-life care

Molecular testing for Clostridium difficile may not predict disease activity

Similar clinical outcomes in mild/moderate Clostridium difficile infection with metronidazole versus vancomycin

Prophylactic LMWH not associated with prevention of VTE after arthroscopy or casting: The POT-KAST and POT-CAST trials

Prophylactic LMWH not associated with prevention of VTE after arthroscopy or casting: The POT-KAST and POT-CAST trials

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.